Cargando…
Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
A large-scale epidemiology study on statins previously showed that simvastatin was unique among statins in reducing the incidence of dementia. Since amyloid beta (Aβ42) is the protein that is most associated with Alzheimer’s disease, this study has focused on how simvastatin influences the turnover...
Autores principales: | Dhakal, Sudip, Subhan, Mishal, Fraser, Joshua M., Gardiner, Kenneth, Macreadie, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678968/ https://www.ncbi.nlm.nih.gov/pubmed/31330953 http://dx.doi.org/10.3390/ijms20143531 |
Ejemplares similares
-
A Toxic Synergy between Aluminium and Amyloid Beta in Yeast
por: Mcdonald, Jamieson B., et al.
Publicado: (2021) -
Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020) -
Trans-Chalcone Plus Baicalein Synergistically Reduce Intracellular Amyloid Beta (Aβ(42)) and Protect from Aβ(42) Induced Oxidative Damage in Yeast Models of Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2021) -
Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2020) -
Finding chemopreventatives to reduce amyloid beta in yeast
por: Macreadie, Ian G., et al.
Publicado: (2016)